ABVC BioPharma Inc (NASDAQ: ABVC): Stock Forecast For 2025 Remains Weak With A Downward Revision Of 35.3%
In the last trading session, 0.16 million shares of the ABVC BioPharma Inc (NASDAQ:ABVC) were traded, and its beta was 0.71. Most recently the company’s